EEF1D

Across TCGA pan-cancer cohorts, EEF1D Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated EEF1D data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher EEF1D Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EEF1D expression acts as an unfavorable survival marker.

THYM, SKCM, and UCEC are the cancer types where EEF1D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	All	0.673	0.978	<.001	31	view →
SKCM	DFS	Median	III,IV	0.172	0.653	.014	7	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
BRCA	OS	Median	All	0.164	0.579	.041	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

EEF1D–THYM (OS)

Open the THYM breakdown →